A Phase Ii Evaluation of Pemetrexed (Alimta, Ly231514, Ind #40061) in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase Ii Study of the Gynecologic Oncology
AuthID
P-00V-T5R
P-00V-T5R